Rhumbline Advisers Artivion, Inc. Put Options Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AORT
# of Institutions
190Shares Held
40MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$286 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$128 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$121 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$120 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.26MShares$97.5 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.74B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...